Göm menyn

Publications for Sten Thorstenson

Co-author map based on Web of Sciences articles 2007-

Publications mentioned in social media 25 times*

Journal Articles

Claes Lundström, Sten Thorstenson, Marie Waltersson, Anders Persson and Darren Treanor
  Summary of 2nd Nordic symposium on digital pathology
  Journal of Pathology Informatics, 2015, 6, .

Sten Thorstenson, Jesper Molin and Claes Lundström
  Implementation of large‑scale routine diagnostics using whole slideimaging in Sweden: Digital pathology experiences 2006-2013
  Journal of Pathology Informatics, 2014, 5(14), .

Cecilia Nilsson, Anthoula Koliadi, Ida Johansson, Cecilia Ahlin, Sten Thorstenson, Leif Bergkvist, Ingrid Hedenfalk and Marie-Louise Fjallskog
  High proliferation is associated with inferior Outcome in male breast cancer patients
  Modern Pathology, 2013, 26(1), 87-94.
 Web of Science® Times Cited: 10

Cecilia Nilsson, Ida Johansson, Cecilia Ahlin, Sten Thorstenson, Rose-Marie Amini, Marit Holmqvist, Leif Bergkvist, Ingrid Hedenfalk and Marie-Louise Fjallskog
  Molecular subtyping of male breast cancer using alternative definitions and its prognostic impact
  Acta Oncologica, 2013, 52(1), 102-109.
 Web of Science® Times Cited: 16

L Arlehag, Gunnar Adell, Annica Knutsen Holmqvist, Sten Thorstenson and Xiao-Feng Sun
  ATM expression in rectal cancers with or without preoperative radiotherapy
  Oncology Reports, 2005, 14(2), 313-317.
 Web of Science® Times Cited: 5

Amir Reza Razavi, Hans Gill, Olle Stål, Marie Sundquist, Sten Thorstenson, Hans Åhlfeldt, Nosrat Shahsavar and The South-East Swedish Breast Cancer Study Group
  Exploring cancer register data to find risk factors for recurrence of breast cancer: Application of Canonical Correlation Analysis
  BMC Medical Informatics and Decision Making, 2005, 5(29), 29-35.
   Fulltext  PDF  

L Ryden, K Jirstrom, PA Bendahl, M Ferno, Bo Nordenskjöld, Olle Stål, Sten Thorstenson, PE Jonsson and G Landberg
  Tumor-specific expression of vascular endothelial growth factor receptor 2 but not vascular endothelial growth factor or human epidermal growth factor receptor 2 is associated with impaired response to adjuvant tamoxifen in premenopausal breast cancer
  Journal of Clinical Oncology, 2005, 23(21), 4695-4704.
 Web of Science® Times Cited: 69

Lisa Rydén, Per-Ebbe Jönsson, Gunilla Chebil, Monika Dufmats, Mårten Fernö, Karin Jirström, Ann-Christine Källström, Göran Landberg, Olle Stål, Sten Thorstenson and Bo Nordenskjöld
  Two years of adjuvant tamoxifen in premenopausal patients with breast cancer: a randomised, controlled trial with long-term follow-up
  European Journal of Cancer, 2005, 41(2), 256-264.
 Web of Science® Times Cited: 75

Marie Sundquist, Sten Thorstenson, Lars Brudin, Sten Wingren and Bo Nordenskjöld
  Incidence and prognosis in early onset breast cancer
  Breast, 2002, 11(1), 30-35.
 Web of Science® Times Cited: 31

Massimiliano Gentile, Åsa Wiman, Sten Thorstenson, Niklas Loman, Åke Borg and Sten Wingren
  Deletion mapping of chromosome segment 11q24-q25, exhibiting extensive allelic loss in early onset breast cancer
  International Journal of Cancer, 2001, 92(2), 208-213.
 Web of Science® Times Cited: 19

Marie Sundquist, Sten Thorstenson, Lars Brudin, Olle Stål and Bo Nordenskjöld
  A comparison between flow cytometric assessment of S-phase fraction and Nottingham histologic grade as prognostic instruments in breast cancer
  Breast Cancer Research and Treatment, 2000, 63(1), 11-15.
 Web of Science® Times Cited: 5

Marie Sundquist, Sten Thorstenson, Claes Klintenberg, Lars Brudin and Bo Nordenskjöld
  Indicators of loco-regional recurrence in breast cancer
  European Journal of Surgical Oncology, 2000, 26(4), 357-362.
 Web of Science® Times Cited: 18

Marie Sundquist, Sten Thorstenson, Lars Brudin and Bo Nordenskjöld
  Applying the Nottingham Prognostic Index to a Swedish breast cancer population
  Breast Cancer Research and Treatment, 1999, 53(1), 1-8.

* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.


Responsible for this page: Peter Berkesand
Last updated: 2017-02-21